SCHEMBL29509652

SCHEMBL29509652

CC(=O)NC(c1cccs1)c1cc(Br)c2cccnc2c1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX12 P18054 14/20 1.00
L3MBTL1 Q9Y468 9/20 1.00
NPC1 O15118 9/20 1.00
RAB9A P51151 8/20 1.00
KDM4E B2RXH2 7/20 0.72
MEN1 O00255 6/20 0.72
KMT2A Q03164 6/20 0.72
TDP1 Q9NUW8 5/20 0.72
LMNA P02545 5/20 0.72
MAPT P10636 4/20 0.72
HTT P42858 4/20 0.72
SMN1; SMN2 Q16637 4/20 0.72
GAA P10253 1/20 0.72
HSP90AA1 P07900 8/20 0.62
ALDH1A1 P00352 3/20 0.61
NPSR1 Q6W5P4 2/20 0.61
BLM P54132 1/20 0.60
PSMD14 O00487 2/20 0.58
MMP2 P08253 2/20 0.58
MDM2 Q00987 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2598269 1.00 ALOX12 (1.00) ALOX12L3MBTL1NPC1RAB9AKDM4E
SCHEMBL2598274 0.89 ALOX12 (1.00) ALOX12L3MBTL1NPC1RAB9AKDM4E
SCHEMBL2598260 0.88 ALOX12 (1.00) ALOX12L3MBTL1NPC1RAB9AKDM4E
SCHEMBL607837 0.88 ALOX12 (1.00) ALOX12L3MBTL1NPC1RAB9AKDM4E
SCHEMBL608048 0.84 KDM4E (1.00) ALOX12L3MBTL1NPC1RAB9AKDM4E
SCHEMBL2598255 0.83 ALOX12 (1.00) ALOX12L3MBTL1NPC1RAB9AKDM4E
SCHEMBL4044485 0.83 RAB9A (0.78) ALOX12L3MBTL1NPC1RAB9AKDM4E
SCHEMBL608473 0.78 ALOX12 (0.81) ALOX12L3MBTL1NPC1RAB9AKDM4E
SCHEMBL609894 0.77 ALOX12 (1.00) ALOX12L3MBTL1NPC1RAB9AKDM4E
SCHEMBL10079880 0.76 ALOX12 (0.72) ALOX12L3MBTL1NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3054936-B1 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO) BENZENESULFONAMIDE DERIVATIVES AS 12-LIPOXYGENASE INHIBITORS EASTERN VIRGINIA MEDICAL SCHOOL (US) 2023-10-18 EP disclosed
US-11274077-B2 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase EASTERN VIRGINIA MEDICAL SCHOOL (US) 2022-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11274077-B2 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase ALOX12, ALOX15, ALOX15B ALOX12 1/4885L3MBTL1 491/4885NPC1 4611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.